Published : Aug-2021
No. of Pages : 41
1 Cystic Fibrosis: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global and Historical Trends
2.3.1 Registry-Based Diagnosed Prevalence of CF
2.3.2 Registry-Based Diagnosed Prevalent Cases Adjusted for Underestimation
2.4 Forecast Methodology
2.4.1 Sources
2.4.2 Sources Not Used
2.4.3 Forecast Assumptions and Methods
2.4.4 Registry-Based Diagnosed Prevalent Cases of CF
2.4.5 Registry-Based Diagnosed Prevalent Cases of CF by Specific Mutation
2.4.6 Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection
2.4.7 Registry-Based Diagnosed Prevalent Cases Adjusted for Underestimation
2.5 Epidemiological Forecast for CF (2020-2030)
2.5.1 Registry-Based Diagnosed Prevalent Cases of CF
2.5.2 Age-Specific Registry-Based Diagnosed Prevalent Cases of CF
2.5.3 Sex-Specific Registry-Based Diagnosed Prevalent Cases of CF
2.5.4 Registry-Based Diagnosed Prevalent Cases of CF with Specific Mutations
2.5.5 Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection
2.5.6 Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation
2.5.7 Age-Specific Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation
2.5.8 Sex-Specific Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation
2.5.9 Registry-Based Diagnosed Prevalent Cases of CF with Specific Mutations Adjusted for Underestimation
2.5.10 Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection Adjusted for Underestimation
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 COVID-19 Impact
2.6.3 Limitations of Analysis
2.6.4 Strengths of Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us
List of Tables
Table 1: Summary of Updated Data Types, Registry-Based Forecast
Table 2: Summary of Updated Data Types, Registry-Based Forecast Adjusted for Underestimation
Table 3: Risk Factors and Comorbidities for CF
List of Figures
Figure 1: 7MM, Registry-Based Diagnosed Prevalent Cases of CF, Both Sexes, All Ages, 2020 and 2030
Figure 2: 7MM, Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation, Both Sexes, All Ages, 2020 and 2030
Figure 3: 7MM, Registry-Based Diagnosed Prevalence of CF, Men and Women, All Ages, 2010-2030 (%)
Figure 4: 7MM, Registry-Based Diagnosed Prevalence of CF Adjusted for Underestimation, Men and Women, All Ages, 2010-2030 (%)
Figure 5: Sources Used for Registry-Based Diagnosed Prevalent Cases of CF
Figure 6: Sources Used for Registry-Based Diagnosed Prevalent Cases of CF by Specific Mutation
Figure 7: Sources Used for Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection
Figure 8: Sources Used for Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation
Figure 9: Registry-Based Diagnosed Prevalent Cases of CF, 7MM, Men and Women, All Ages, 2020
Figure 10: 7MM, Age-Specific Registry-Based Diagnosed Prevalent Cases of CF, Men and Women, 2020 (N)
Figure 11: 7MM, Sex-Specific Registry-Based Diagnosed Prevalent Cases of CF, All Ages, 2020 (N)
Figure 12: 7MM, Registry-Based Diagnosed Prevalent Cases of CF with Specific Mutations, Men and Women, All Ages, 2020 (N)
Figure 13: 7MM, Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection, Men and Women, All Ages, 2020 (N)
Figure 14: Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation, 7MM, Men and Women, All Ages, 2020
Figure 15: 7MM, Age-Specific Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation, Men and Women, 2020 (N)
Figure 16: 7MM, Sex-Specific Registry-Based Diagnosed Prevalent Cases of CF Adjusted for Underestimation, All Ages, 2020 (N)
Figure 17: 7MM, Registry-Based Diagnosed Prevalent Cases of CF with Mutations Adjusted for Underestimation, Men and Women, All Ages, 2020 (N)
Figure 18: 7MM, Registry-Based Diagnosed Prevalent Cases of CF with Chronic MRSA Infection Adjusted for Underestimation, Men and Women, All Ages, 2020 (N)
